China In-Vitro Diagnostics Market is expected to grow with 19% CAGR by 2022

1
China In-Vitro Diagnostics Market is expected to grow with 19 CAGR by 2022
Category Life Science
2
China In-Vitro Diagnostics Market is expected to
grow with 19 CAGR by 2022 Analyst View The
report China In-Vitro Diagnostics Market,
Forecast, Companies Analysis, Registration Rules
The market for China In-Vitro Diagnostics (IVD)
is likely to be thrice of its present market,
growing at a CAGR of 19 by 2022. Press Release
Title China In-Vitro Diagnostics Market is
expected to grow with 19 CAGR by 2022 For More
Information http//www.renub.com/china-in-vitro-d
iagnostics-market-is-expected-to-grow-with-19-cagr
-by-2022-32-nd.php

3
China In-Vitro Diagnostics Market is expected to
grow with 19 CAGR by 2022
Download full Report http//www.renub.com/china-i
n-vitro-diagnostics-ivd-market-forecast-companies-
analysis-registration-rules-1089-p.php In Vitro
Diagnostics (IVDs) - Devices and Reagents In
Vitro Diagnostics (IVDs) are medical devices and
accessories that are used to perform tests on the
specimens taken from the human body such as
blood, urine and tissue in order to treat,
mitigate, monitor drug therapies, cure, or
prevent illness or its abnormality. In vitro
diagnostic (IVD) products are those reagents,
instruments, and systems intended for use in the
collection, preparation, and examination of
specimens to diagnose disease or other
conditions, including a decision of the state of
health. A Look on China In Vitro Diagnostic
(IVD) Market By Testing, the Immunoassay
accounted for the largest share of the market in
2016 while Microbiology Market has grown
approximately 4 times in 2016 compared to its
market value in 2007 driven by growing prevalence
of chronic lifestyle diseases, increasing aging
population and demand for tests in urban and
rural areas.

4
China In-Vitro Diagnostics Market is expected to
grow with 19 CAGR by 2022
In Vitro Diagnostic (IVD) Enhancing Healthcare
System In vitro diagnostic (IVD) is an important
segment of the healthcare industry. The market is
observing rapid growth ignited by technological
enhancements, better diagnostic devices and
tools, advanced monitoring systems, and increased
availability of over-the-counter tests. IVDs add
momentous value to healing processes and medical
diagnoses, strengthening the well-being of the
general public. FDA Approval and Process FDA
classifies IVD products into Class I, II, or III
according to the level of regulatory regulations,
with the aim to assure safety and effectiveness.
The classification of an IVD (or other medical
devices) determines the suitable premarket
approval and process. Class I Class
II Class III

5
China In-Vitro Diagnostics Market is expected to
grow with 19 CAGR by 2022



6
China In-Vitro Diagnostics Market is expected to
grow with 19 CAGR by 2022
The Report Studies the China IVD Market on the
basis of Segment Analysis (2007 2022)
1. Clinical Chemistry Market 2.
Immunoassay Market 3. Hematology Market 4.
Coagulation Market 5. Microbiology
Market 6. Molecular Testing Market 7. Self
Monitoring of Blood Glucose (SMBG) Market 8.
Point of Care Testing (POCT) Market

Key Players (2011 2022) 1. Roche Diagnostics
2. Sysmex Corporation 3. Mindray Medical
International Limited 4. Shanghai Kehua
Bio-Engineering Co. Ltd. 5. Abbott
Laboratories 6. Others
7
China In-Vitro Diagnostics Market is expected to
grow with 19 CAGR by 2022
Life Science News http//www.renub.com/life-scie
nce-1-n.php

•  Renub Research - North America
• Rajat Gupta
• 225 Kristie Ln, Roswell
• Georgia 30076, United States
• Tel [phone]
• Email info_at_renub.com
• www.renub.com
•  
• Renub Research - Asia
• Ankit Mishra
• C 86, Sector 10
• Noida 201301, India
• Tel [phone]